A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration.
We analyzed hemolytic reaction following vinca alkaloid administration in patients with acute lymphoblastic leukemia, blast crisis of chronic myelogenous leukemia and malignant lymphoma in the leukemic phase. During the course of chemotherapy in which vinca alkaloids were included, indirect-form dominant hyperbilirubinemia was observed in 21 of the 31 evaluable patients. In 8 patients with hyperbilirubinemia, reticulocytosis coincided with vinca alkaloid administration. Peripheral blood films showed prominent anisocytosis in 4 patients and increased stomatocytes in 10 patients. Red cell membrane studies in patients with hemolysis revealed increased sodium transport and increased activity of Na+, K+-ATPase. These findings were considered to represent the abnormal membrane "leakiness". Thus, vinca alkaloids might induce erythrocytotoxicity, which leads to acquired stomatocytosis with hemolysis in some patients.
Ohsaka
A
A
Kano
Y
Y
Sakamoto
S
S
Kanzaki
A
A
Hashimoto
M
M
Yawata
Y
Y
Miura
Y
Y
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000743:Anemia, Hemolytic / Q000209:etiology*; D004910:Erythrocyte Membrane / Q000378:metabolism; D005260:Female; D006402:Hematologic Diseases / Q000097:blood* / Q000150:complications; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood; D014748:Vinca Alkaloids / Q000009:adverse effects*
D014748:Vinca Alkaloids